Medical Device

Reinforces Medtronic's Commitment to Diversity
and Empowering Women to Lead at All Levels

 Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE: MDT) — the world's largest medical technology, services, and solutions company — has been named on the 2021 lists of Top 50 Great Places to Work in Canada and Best Workplaces™ for Women for the second consecutive year after a thorough and independent analysis conducted by Great Place to Work®.

Medtronic Canada recognized among Best Workplaces for Women 2021 (CNW Group/Medtronic Canada ULC)

"Our Mission has always been the mainstay of our identity — to contribute to human welfare," said Yvonne Farquharson , director of Human Resources, Medtronic Canada. "In this past year, tenet five of the Medtronic Mission, which reinforces the personal worth of all employees, has been especially resonant. We have focused on employee's health and safety, staying connected virtually, and fostering a workplace where everyone can thrive."

Medtronic has always strived to maintain a sense of connection among employees, especially since pivoting to a remote work model for most employees. This has been addressed through various initiatives, including bi-weekly virtual all-employee meetings.

In these meetings, employees have rallied together to support and learn from each other. The calls have featured guest speakers, including a diversity and inclusion advocate who facilitated a meaningful conversation about anti-racism.

Diversity and inclusion have been an important focus at Medtronic for many years. Medtronic has a strong foundation with active employee resource groups, networking circles and development programs. The efforts by Medtronic to advance women has earned the esteemed Catalyst recognition in 2020. At Medtronic Canada, women account for over 50% of all employees and 55% of the Canadian Leadership Team.

"The importance of fostering a diverse workforce and supporting our women colleagues at all levels is ingrained in our organization's culture," shares Neil Fraser , president of Medtronic Canada. "Having an inclusive, diverse and equitable environment leads to innovation, which enables us to continue providing life-saving technology to people all around the world."

Organizations on these lists must be Great Place to Work-Certified™ in the past year, headquartered in Canada and at least 90% of employees must agree that people are treated fairly, regardless of their gender. Recognition on these two lists is one of many honours Medtronic Canada has received over the past year.

Medtronic was recognized by Forbes as one of Canada's Best Employers in January 2021 , and in 2020, was ranked as among Canada's Top 100 Employers and the GTA's top employers by Media Corp. It was also ranked one of Canada's Best Workplaces in Healthcare , one of the Best Workplaces for Mental Wellness in Canada , and one of the Best Workplaces in Ontario by the Great Place to Work Institute of Canada .

Medtronic is the largest medical device employer in Canada , with over 1,100 employees. In 2020 alone, Medtronic innovation and technology benefitted 75 million people globally — that's two people every second.

About Great Place to Work®
Great Place to Work is the global authority on high-trust, high-performance workplace cultures. Through proprietary assessment tools, advisory services, and certification programs, GPTW recognizes the world's Best Workplaces in a series of national lists including those published by The Globe & Mail ( Canada ) and Fortune magazine ( USA ). Great Place to Work provides the benchmarks, framework, and expertise needed to create, sustain, and recognize outstanding workplace cultures. Visit us at www.greatplacetowork.ca

About Medtronic Canada ULC
Proudly serving Canadian healthcare for over 50 years, Medtronic Canada ULC ( www.medtronic.ca ) is a subsidiary of Medtronic plc, the world's largest medical technology, services, and solutions companies — alleviating pain, restoring health, and extending life for millions of people around the world. Serving physicians, hospitals, and patients across the country, Medtronic Canada ULC is headquartered in Brampton, Ontario , with regional offices in Montreal and Vancouver , and a Medtronic Resource Centre in Surrey, BC . The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the U.S. Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Medtronic Logo (CNW Group/Medtronic Canada ULC)

SOURCE Medtronic Canada ULC

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/April2021/14/c4243.html

News Provided by Canada Newswire via QuoteMedia

Applied UV Announces Order for The Renaissance Cleveland Hotel

Applied UV Announces Order for The Renaissance Cleveland Hotel

$2M Furnishings Order Expected Subject to Initial "Model Room" Product Approval

Applied UV, Inc. (NasdaqCM: AUVI ) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announces that its wholly owned subsidiary MunnWorks, a custom manufacturer of luxury mirrors and furniture for the hospitality market, has received a model room order from The Renaissance Cleveland Hotel , which will be fully funded by the developer of the hotel. Upon successful acceptance of the "Model Room" order, a follow-on $2M order is expected. This order for hotel furniture will be manufactured in MunnWorks 100,000 square foot Brooklyn, NY manufacturing facility, which MunnWorks acquired on March 31 st , 2022, through the purchase of VisionMark LLC's luxury furniture manufacturing business.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Medtronic receives FDA approval for latest generation drug-eluting coronary stent system

The Onyx Frontier™ drug-eluting stent offers an innovative delivery system and builds upon the acute performance and clinical data from the Resolute Onyx™ drug-eluting stent

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it received U.S. Food and Drug Administration (FDA) approval for the Onyx Frontier™ drug-eluting stent (DES). As the latest evolution in the Resolute DES family, Onyx Frontier DES leverages the same best-in-class stent platform as Resolute Onyx™ DES, with an enhanced delivery system 1 designed to improve deliverability and increase acute performance 2 in even the most challenging of cases. 1

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Danaher Joins Bespoke Gene Therapy Consortium for Rare Diseases

Consortium aims to speed the development and delivery of customized or 'bespoke' gene therapies

Danaher Corporation (NYSE: DHR) announced that it has joined the Bespoke Gene Therapy Consortium (BGTC). Launched in October 2021 the BGTC will generate gene therapy resources that the research community can use to streamline gene therapy development for rare disorders, making the process more efficient and less costly. Danaher's Life Science companies join the Food and Drug Administration (FDA), the National Institutes of Health (NIH), twelve pharmaceutical and biotech companies and nine non-profits, and will be represented by experts from Danaher Corporation and its companies, notably Pall Corporation, Aldevron and Cytiva. The project is managed by the Foundation for the National Institutes of Health (FNIH) as part of the Accelerating Medicines Partnership® program.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 43 rd Annual Global Healthcare Conference at the Terranea Resort, Rancho Palos Verdes, CA on Thursday, June 16 th . Jennifer Taubert Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time) .

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 43 rd Annual Global Healthcare Conference at the Terranea Resort, Rancho Palos Verdes, CA on Thursday, June 16 th . Jennifer Taubert Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time) .

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Knight Therapeutics Reports First Quarter 2022 Results

Knight Therapeutics Inc. (TSX: GUD) ("Knight" or "the Company"), a leading Pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its first quarter ended March 31, 2022. All currency amounts are in thousands except for share and per share amounts. All currencies are Canadian unless otherwise specified.

Q1 2022 Highlights

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×